Zymeworks Inc. Contracts & Agreements
35 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (3)
- Human Resources (10)
- Real Estate (2)
- Uncategorized (8)
- Open Market Sale AgreementSM, dated October 21, 2022, by and between Zymeworks Inc. and Jefferies LLC (Filed With SEC on October 21, 2022)
- Restated and Amended Transaction Agreement, dated August 18, 2022, by and among Zymeworks, Parent, Callco, and ExchangeCo (Filed With SEC on August 19, 2022)
- Lease Amending Agreement, dated April 1, 2022, by and between the Company and 130 E 4th Partnership (Filed With SEC on August 4, 2022)
- Notice of Assignment of Lease, dated January 1, 2022 from 5 (Filed With SEC on August 4, 2022)
- Third Amendment to Collaboration and Cross License Agreement, effective June 6, 2022, by and between the Company and Daiichi Sankyo Co., Ltd (Filed With SEC on August 4, 2022)
- Employment Agreement by and between the Company, Zymeworks Biopharmaceuticals Inc. and Paul Moore, dated July 18, 2022 (Filed With SEC on August 4, 2022)
- Transaction Agreement, dated July 14, 2022, by and among Zymeworks, Parent, Callco, and ExchangeCo (Filed With SEC on July 15, 2022)
- Resolutions of the Board of Directors of Zymeworks, Inc. (incorporated by reference to Exhibit A of Exhibit 4.1 hereto) (Filed With SEC on June 10, 2022)
- Zymeworks Inc. Executive Incentive Compensation Plan (Filed With SEC on March 9, 2022)
- Amended and Restated Employment Agreement by and between the Company and Christopher Astle, effective February 24, 2022 (Filed With SEC on February 25, 2022)
- Specimen common share certificate (Filed With SEC on February 24, 2022)
- Separation and Release Agreement by and between the Company and James Priour, dated (Filed With SEC on February 24, 2022)
- Letter, dated November 9, 2021, from the (Filed With SEC on February 24, 2022)
- Underwriting Agreement dated January 26, 2022 (Filed With SEC on January 27, 2022)
- Form of Pre-Funded Warrant to Purchase Common Shares (Filed With SEC on January 27, 2022)
- Employment Agreement by and between the Company and Kenneth Galbraith, dated January 5, 2022 (Filed With SEC on January 5, 2022)
- Separation Agreement and Release by and between the Company and Ali Tehrani, dated January 5, 2022 (Filed With SEC on January 5, 2022)
- Promotion Letter from the Company to Neil Klompas, dated January 5, 2022 (Filed With SEC on January 5, 2022)
- Zymeworks Inc. Inducement Stock Option and Equity Compensation Plan (Filed With SEC on January 5, 2022)
- Amendment No. 1 to the Open Market Sale AgreementSM, dated October 1, 2021, by and between Zymeworks Inc. and Jefferies LLC (Filed With SEC on October 1, 2021)
- Employment Agreement, effective April 29, 2019, by and between the Registrant and Neil Josephson (Filed With SEC on August 4, 2021)
- Letter, dated May 16, 2021, from the Registrant to Neil Josephson (Filed With SEC on August 4, 2021)
- Employment Agreement, effective April 1, 2020, by and between the Registrant and James Priour (Filed With SEC on May 5, 2021)
- Letter, dated March 3, 2021, from the Registrant to James Priour (Filed With SEC on May 5, 2021)
- First Amendment to Collaboration Agreement, dated May 25, 2020, by and between Zymeworks Inc. and BeiGene, Ltd (Filed With SEC on August 5, 2020)
- Third Amendment to Collaboration Agreement, dated June 22, 2020, by and between Zymeworks Inc., Celgene Corporation and Celgene Alpine Investment Co. LLC (Filed With SEC on August 5, 2020)
- Zymeworks Amended and Restated Stock Option and Equity Compensation Plan (Filed With SEC on May 7, 2020)
- Registration Rights Agreement dated March 16, 2020, by and among Zymeworks Inc., Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on March 16, 2020)
- Description of Capital Stock (Filed With SEC on March 2, 2020)
- Employment Agreement effective October 14, 2019, by and between the Registrant and Kathryn ODriscoll (Filed With SEC on March 2, 2020)
- Underwriting Agreement dated January 22, 2020 (Filed With SEC on January 24, 2020)
- Form of Pre-Funded Warrant to Purchase Common Shares (Filed With SEC on January 24, 2020)
- Open Market Sale AgreementSM, dated November 5, 2019, between Zymeworks Inc. and Jefferies LLC (Filed With SEC on November 6, 2019)
- Indenture of Lease dated as of January 25, 2019, by and between 5th & Main Partnership and Zymeworks Inc (Filed With SEC on March 6, 2019)
- Employment Agreement effective September 17, 2018, by and between the Registrant and Anthony Polverino (Filed With SEC on March 6, 2019)